{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T14:47:40Z","timestamp":1791557260513,"version":"4.3.4"},"reference-count":56,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T00:00:00Z","timestamp":1737763200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,25]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The clinical and microbiological characteristics of invasive aspergillosis (IA) caused by cryptic Aspergillus species have not been well-defined in transplant settings. However, IA is among the most common mould infections in solid organ and hematopoietic stem cell transplant recipients. Among 55 causative isolates in the 53 reported cases, Aspergillus calidoustus, A. lentulus, A. tubingensis, and A. udagawae were the four most common causative cryptic Aspergillus species. Newer diagnostic modalities, such as matrix-assisted laser desorption ionization-time of flight mass spectrometry, may help diagnose these cryptic species. Of the 24 cases with detailed clinical information, 13 had antifungal breakthrough infections. The 12-week mortality rates of all 24 cases, 7 cases of A. calidoustus, and 7 cases of A. lentulus were 46%, 43%, and 43%, respectively. Based on antifungal susceptibility profiles obtained from previous studies, an empiric antifungal regimen such as liposomal amphotericin B with or without echinocandin is recommended for A. calidoustus. A combination of an anti-mould azole and liposomal amphotericin B with or without an echinocandin is suggested for A. lentulus and A. udagawae. Additionally, any one of voriconazole, isavuconazole, or posaconazole with or without liposomal amphotericin B with or without an echinocandin is indicated for A. tubingensis. Newer antifungal agents may have more significant activity against Aspergillus cryptic species.<\/jats:p>","DOI":"10.1093\/mmy\/myaf015","type":"journal-article","created":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T00:06:21Z","timestamp":1739318781000},"source":"Crossref","is-referenced-by-count":5,"title":["Invasive aspergillosis caused by cryptic species in transplant recipients: A review"],"prefix":"10.1093","volume":"63","author":[{"given":"Muneyoshi","family":"Kimura","sequence":"first","affiliation":[{"name":"Transplant Infectious Diseases, Ajmera Transplant Program, University Health Network , Toronto, Ontario, M5G 2N2 ,","place":["Canada"]},{"name":"Department of infectious diseases, Toranomon Hospital , Tokyo, 105-8470 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9216-5229","authenticated-orcid":false,"given":"Shahid","family":"Husain","sequence":"additional","affiliation":[{"name":"Transplant Infectious Diseases, Ajmera Transplant Program, University Health Network , Toronto, Ontario, M5G 2N2 ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,2,11]]},"reference":[{"issue":"9","key":"2025030418400962600_bib1","doi-asserted-by":"publisher","first-page":"e13544","DOI":"10.1111\/ctr.13544","article-title":"Invasive aspergillosis in solid-organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Husain","year":"2019","journal-title":"Clin Transplant"},{"issue":"4","key":"2025030418400962600_bib2","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"3","key":"2025030418400962600_bib3","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1128\/CMR.00055-08","article-title":"Pathogenesis of Aspergillus fumigatus in invasive aspergillosis","volume":"22","author":"Dagenais","year":"2009","journal-title":"Clin Microbiol Rev"},{"issue":"7","key":"2025030418400962600_bib4","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1086\/339202","article-title":"Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients","volume":"34","author":"Marr","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"8","key":"2025030418400962600_bib5","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.cmi.2016.05.013","article-title":"Previously unknown species of Aspergillus","volume":"22","author":"Gautier","year":"2016","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"2025030418400962600_bib6","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1128\/ec.4.3.625-632.2005","article-title":"Aspergillus lentulus sp. nov., a new sibling species of A. fumigatus","volume":"4","author":"Balajee","year":"2005","journal-title":"Euk Cell"},{"issue":"4","key":"2025030418400962600_bib7","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1128\/EC.00425-07","article-title":"Aspergillus calidoustus sp. nov., causative agent of human infections previously assigned to Aspergillus ustus","volume":"7","author":"Varga","year":"2008","journal-title":"Euk Cell"},{"issue":"7","key":"2025030418400962600_bib8","doi-asserted-by":"publisher","first-page":"3380","DOI":"10.1128\/AAC.00383-13","article-title":"Population-based survey of filamentous fungi and antifungal resistance in Spain (FILPOP Study)","volume":"57","author":"Alastruey-Izquierdo","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"2025030418400962600_bib9","doi-asserted-by":"publisher","first-page":"3138","DOI":"10.1128\/jcm.01070-09","article-title":"Molecular identification of Aspergillus species collected for the Transplant-Associated Infection Surveillance Network","volume":"47","author":"Balajee","year":"2009","journal-title":"J Clin Microbiol"},{"issue":"30","key":"2025030418400962600_bib10","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.1200\/jco.18.00374","article-title":"Antimicrobial prophylaxis for adult patients with cancer-related immunosuppression: ASCO and IDSA Clinical Practice Guideline Update","volume":"36","author":"Taplitz","year":"2018","journal-title":"J Clin Oncol"},{"key":"2025030418400962600_bib11","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.simyco.2014.07.004","article-title":"Phylogeny, identification and nomenclature of the genus Aspergillus","volume":"78","author":"Samson","year":"2014","journal-title":"Stud Mycol"},{"issue":"6","key":"2025030418400962600_bib12","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"1","key":"2025030418400962600_bib13","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1186\/s12879-018-3527-5","article-title":"Aspergillus pseudodeflectus: A new human pathogen in liver transplant patients","volume":"18","author":"A\u00eft-Ammar","year":"2018","journal-title":"BMC Infect Dis"},{"issue":"3\u20134","key":"2025030418400962600_bib14","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s11046-014-9840-7","article-title":"Early invasive pulmonary aspergillosis in a kidney transplant recipient caused by Aspergillus lentulus: First Brazilian report","volume":"179","author":"Bastos","year":"2015","journal-title":"Mycopathologia"},{"key":"2025030418400962600_bib15","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/1471-2334-13-59","article-title":"Involvement of the opportunistic pathogen Aspergillus tubingensis in osteomyelitis of the maxillary bone: A case report","volume":"13","author":"Bathoorn","year":"2013","journal-title":"BMC Infect Dis"},{"issue":"3","key":"2025030418400962600_bib16","doi-asserted-by":"publisher","first-page":"e0220621","DOI":"10.1128\/aac.02206-21","article-title":"Successful treatment of disseminated disease due to highly resistant Aspergillus calidoustus with a novel antifungal therapy","volume":"66","author":"Camargo","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"2025030418400962600_bib17","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s11046-017-0223-8","article-title":"Proven invasive pulmonary aspergillosis in stem cell transplant recipient due to Aspergillus sublatus, a cryptic species of A. nidulans","volume":"183","author":"Chrenkova","year":"2018","journal-title":"Mycopathologia"},{"issue":"4","key":"2025030418400962600_bib18","doi-asserted-by":"publisher","first-page":"429","DOI":"10.5152\/balkanmedj.2013.8572","article-title":"Report on Aspergillus lentulus pneumonia","volume":"30","author":"G\u00fcrcan","year":"2013","journal-title":"Balkan Med J"},{"issue":"11","key":"2025030418400962600_bib19","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1111\/myc.13348","article-title":"Invasive aspergillosis due to Aspergillus cryptic species: A prospective multicentre study","volume":"64","author":"Imbert","year":"2021","journal-title":"Mycoses"},{"issue":"7","key":"2025030418400962600_bib20","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1128\/jcm.00216-14","article-title":"Misidentification of Neosartorya pseudofischeri as Aspergillus fumigatus in a lung transplant patient","volume":"52","author":"Khare","year":"2014","journal-title":"J Clin Microbiol"},{"issue":"4","key":"2025030418400962600_bib21","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1128\/jcm.02919-12","article-title":"Invasive sino-orbital mycosis in an aplastic anemia patient caused by Neosartorya laciniosa","volume":"51","author":"Malejczyk","year":"2013","journal-title":"J Clin Microbiol"},{"issue":"2","key":"2025030418400962600_bib22","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s11046-019-00423-x","article-title":"Successful treatment of invasive fungal infection due to highly resistant Aspergillus calidoustus in an allogeneic hematopoietic cell transplant recipient","volume":"185","author":"Mendoza","year":"2020","journal-title":"Mycopathologia"},{"issue":"Pt 3","key":"2025030418400962600_bib23","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1099\/jmm.0.005942-0","article-title":"Phenotypic and genotypic characterization of Aspergillus lentulus and Aspergillus fumigatus isolates in a patient with probable invasive aspergillosis","volume":"58","author":"Montenegro","year":"2009","journal-title":"J Med Microbiol"},{"issue":"8","key":"2025030418400962600_bib24","doi-asserted-by":"publisher","first-page":"ofab392","DOI":"10.1093\/ofid\/ofab392","article-title":"Aspergillus lentulus: An under-recognized cause of antifungal drug-resistant aspergillosis","volume":"8","author":"Nematollahi","year":"2021","journal-title":"Open Forum Infect Dis"},{"issue":"Pt 3","key":"2025030418400962600_bib25","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1099\/jmm.0.044867-0","article-title":"Invasive aspergillosis caused by cryptic Aspergillus species: A report of two consecutive episodes in a patient with leukaemia","volume":"62","author":"Pel\u00e1ez","year":"2013","journal-title":"J Med Microbiol"},{"key":"2025030418400962600_bib26","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.carpath.2017.02.002","article-title":"Fatal fungal endocarditis by Aspergillus udagawae: An emerging cause of invasive aspergillosis","volume":"28","author":"Seki","year":"2017","journal-title":"Cardiovasc Pathol"},{"issue":"5","key":"2025030418400962600_bib27","doi-asserted-by":"publisher","DOI":"10.1111\/tid.12755","article-title":"Aspergillus calidoustus case series and review of the literature","volume":"19","author":"Seroy","year":"2017","journal-title":"Transpl Infect Dis"},{"issue":"7","key":"2025030418400962600_bib28","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1093\/cid\/ciac205","article-title":"Disseminated Aspergillus lentulus infection in a heart transplant recipient: A case report","volume":"75","author":"Shivasabesan","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"4","key":"2025030418400962600_bib29","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.jiac.2018.10.016","article-title":"Successful treatment of invasive pulmonary aspergillosis caused by Aspergillus felis, a cryptic species within the Aspergillus section Fumigati: A case report","volume":"25","author":"Yamairi","year":"2019","journal-title":"J Infect Chemother"},{"issue":"1","key":"2025030418400962600_bib30","doi-asserted-by":"publisher","first-page":"e0163021","DOI":"10.1128\/aac.01630-21","article-title":"Clinical and microbiological characteristics of proven invasive aspergillosis due to rare\/cryptic species in allogeneic hematopoietic stem cell transplant recipients","volume":"66","author":"Yamamuro","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"2025030418400962600_bib31","doi-asserted-by":"publisher","first-page":"E60","DOI":"10.1111\/j.1399-3062.2012.00779.x","article-title":"Fatal outcome after heart transplantation caused by Aspergillus lentulus","volume":"14","author":"Zbinden","year":"2012","journal-title":"Transpl Infect Dis"},{"issue":"6","key":"2025030418400962600_bib32","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1093\/jac\/dkz078","article-title":"In vitro activity of olorofim (F901318) against clinical isolates of cryptic species of Aspergillus by EUCAST and CLSI methodologies","volume":"74","author":"Rivero-Menendez","year":"2019","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"2025030418400962600_bib33","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1086\/345441","article-title":"Trends in risk profiles for and mortality associated with invasive aspergillosis among liver transplant recipients","volume":"36","author":"Singh","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"4","key":"2025030418400962600_bib34","doi-asserted-by":"publisher","first-page":"e12898","DOI":"10.1111\/tid.12898","article-title":"Epidemiology, risk factors and outcomes of invasive aspergillosis in solid organ transplant recipients in the Swiss Transplant Cohort Study","volume":"20","author":"Neofytos","year":"2018","journal-title":"Transpl Infect Dis"},{"key":"2025030418400962600_bib35","article-title":"Voriconazole breakpoints for Aspergillus fumigatus","volume-title":"CLSI Rationale Document","author":"Clinical and Laboratory Standards Institute","year":"2024"},{"issue":"5","key":"2025030418400962600_bib36","doi-asserted-by":"publisher","first-page":"e0028022","DOI":"10.1128\/jcm.00280-22","article-title":"Species distribution and antifungal susceptibilities of Aspergillus section Fumigati isolates in clinical samples from the United States","volume":"60","author":"Badali","year":"2022","journal-title":"J Clin Microbiol"},{"key":"2025030418400962600_bib37","first-page":"M57","article-title":"Epidemiological cutoff values for antifungal susceptibility testing","volume-title":"Document","author":"Clinical and Laboratory Standard Institute","year":"2022"},{"issue":"11","key":"2025030418400962600_bib38","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1093\/jac\/dky280","article-title":"Rezafungin (CD101) demonstrates potent in vitro activity against Aspergillus, including azole-resistant Aspergillus fumigatus isolates and cryptic species","volume":"73","author":"Wiederhold","year":"2018","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"2025030418400962600_bib39","doi-asserted-by":"publisher","DOI":"10.1128\/aac.02583-16","article-title":"Drug sensitivity and resistance mechanism in Aspergillus Section Nigri strains from Japan","volume":"61","author":"Hashimoto","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"2025030418400962600_bib40","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.02023-18","article-title":"Epidemiology and antifungal susceptibility profile of Aspergillus species: Comparison between environmental and clinical isolates from patients with hematologic malignancies","volume":"57","author":"Cho","year":"2019","journal-title":"J Clin Microbiol"},{"issue":"12","key":"2025030418400962600_bib41","doi-asserted-by":"publisher","first-page":"e383","DOI":"10.1016\/s1473-3099(17)30316-x","article-title":"The global problem of antifungal resistance: Prevalence, mechanisms, and management","volume":"17","author":"Perlin","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"2025030418400962600_bib42","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1128\/jcm.03233-14","article-title":"Identification and susceptibility of Aspergillus section Nigri in China: Prevalence of species and paradoxical growth in response to echinocandins","volume":"53","author":"Li","year":"2015","journal-title":"J Clin Microbiol"},{"issue":"3","key":"2025030418400962600_bib43","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00069-19","article-title":"Antifungal susceptibility testing: Current approaches","volume":"33","author":"Berkow","year":"2020","journal-title":"Clin Microbiol Rev"},{"key":"2025030418400962600_bib44","doi-asserted-by":"publisher","first-page":"683","DOI":"10.3389\/fmicb.2016.00683","article-title":"Aspergillus fumigatus-related species in clinical practice","volume":"7","author":"Lamoth","year":"2016","journal-title":"Front Microbiol"},{"issue":"8","key":"2025030418400962600_bib45","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1093\/cid\/ciaa230","article-title":"Invasive aspergillosis due to Aspergillus section Usti: A multicenter retrospective study","volume":"72","author":"Glampedakis","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"10273","key":"2025030418400962600_bib46","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/s0140-6736(21)00219-1","article-title":"Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: A phase 3, randomised, controlled, non-inferiority trial","volume":"397","author":"Maertens","year":"2021","journal-title":"Lancet"},{"issue":"2","key":"2025030418400962600_bib47","doi-asserted-by":"publisher","first-page":"81","DOI":"10.7326\/m13-2508","article-title":"Combination antifungal therapy for invasive aspergillosis: A randomized trial","volume":"162","author":"Marr","year":"2015","journal-title":"Ann Intern Med"},{"issue":"10","key":"2025030418400962600_bib48","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1093\/cid\/ciy473","article-title":"Breakthrough invasive mold infections in the hematology patient: Current concepts and future directions","volume":"67","author":"Lionakis","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"12","key":"2025030418400962600_bib49","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1002\/cncr.23109","article-title":"Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies: A randomized pilot study (combistrat trial)","volume":"110","author":"Caillot","year":"2007","journal-title":"Cancer"},{"issue":"9","key":"2025030418400962600_bib50","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1128\/jcm.00962-16","article-title":"Identification by molecular methods and matrix-assisted laser desorption ionization-time of flight mass spectrometry and antifungal susceptibility profiles of clinically significant rare Aspergillus species in a Referral Chest Hospital in Delhi, India","volume":"54","author":"Masih","year":"2016","journal-title":"J Clin Microbiol"},{"issue":"3","key":"2025030418400962600_bib51","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1093\/cid\/ciab1070","article-title":"Investigational antifungal agents for invasive mycoses: A clinical perspective","volume":"75","author":"Lamoth","year":"2022","journal-title":"Clin Infect Dis"},{"key":"2025030418400962600_bib52","doi-asserted-by":"publisher","first-page":"1018202","DOI":"10.3389\/fimmu.2022.1018202","article-title":"Checkpoint inhibitors as immunotherapy for fungal infections: Promises, challenges, and unanswered questions","volume":"13","author":"Wurster","year":"2022","journal-title":"Front Immunol"},{"key":"2025030418400962600_bib53","doi-asserted-by":"publisher","first-page":"900522","DOI":"10.3389\/fimmu.2022.900522","article-title":"Case report: Immune checkpoint blockade plus interferon-\u0393 add-on antifungal therapy in the treatment of refractory covid-associated pulmonary aspergillosis and cerebral mucormycosis","volume":"13","author":"Serris","year":"2022","journal-title":"Front Immunol"},{"issue":"3","key":"2025030418400962600_bib54","doi-asserted-by":"publisher","first-page":"e530","DOI":"10.1097\/hs9.0000000000000530","article-title":"Immune checkpoint blockade for aspergillosis and mucormycosis coinfection","volume":"5","author":"Banck","year":"2021","journal-title":"Hemasphere"},{"issue":"4","key":"2025030418400962600_bib55","doi-asserted-by":"publisher","first-page":"e0341323","DOI":"10.1128\/mbio.03413-23","article-title":"A novel lentiviral vector-based approach to generate chimeric antigen receptor T cells targeting Aspergillus fumigatus","volume":"15","author":"Kumaresan","year":"2024","journal-title":"mBio"},{"issue":"1","key":"2025030418400962600_bib56","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1093\/cid\/ciae203","article-title":"Breakthrough invasive fungal infections in patients with high-risk hematological disorders receiving voriconazole and posaconazole prophylaxis: A systematic review","volume":"79","author":"Boutin","year":"2024","journal-title":"Clin Infect Dis"}],"container-title":["Medical Mycology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/mmy\/advance-article-pdf\/doi\/10.1093\/mmy\/myaf015\/61851343\/myaf015.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mmy\/article-pdf\/63\/2\/myaf015\/61851343\/myaf015.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mmy\/article-pdf\/63\/2\/myaf015\/61851343\/myaf015.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T20:46:52Z","timestamp":1741121212000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mmy\/article\/doi\/10.1093\/mmy\/myaf015\/8009096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,25]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,1,25]]}},"URL":"https:\/\/doi.org\/10.1093\/mmy\/myaf015","relation":{},"ISSN":["1369-3786","1460-2709"],"issn-type":[{"value":"1369-3786","type":"print"},{"value":"1460-2709","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,2]]},"published":{"date-parts":[[2025,1,25]]},"article-number":"myaf015"}}